omniture

China Sky One Medical Attended Import and Export Fair to Enhance International Growth Opportunity

2010-05-11 20:58 2030

HARBIN, China, May 11 /PRNewswire-Asia/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China ("PRC"), today announced the Company attended the 107th China Import and Export Fair (Canton Fair) in Guangzhou from May 1st to 5th, 2010 and generated significant interest from many overseas distributors.

(Photo: http://www.prnasia.com/sa/2010/05/11/20100511502294.jpg )

At the Canton Fair, over 700 distributors visited China Sky One's booth, drawn to the Company's rich product portfolio, especially its proprietary traditional Chinese medicine (TCM) offerings. China Sky One received strong interest of future cooperation from over 100 distributors, including more than 30 from Thailand, Indonesia, Mexico, Russia, India, the Philippines and other countries, who signed Letters of Intent to advance discussions of possible future international commercial opportunities. Many of these distributors also purchased small quantities of the Company's products for trial distribution in their respective markets.

"We are excited by the interest from so many distributors in China Sky One at the Canton Fair and capitalized on the opportunity to introduce our Company and our diverse product offering to this wide audience of potential future customers," said Mr. Yan-Qing Liu, Chairman and CEO of China Sky One Medical. "We look forward to continuing active dialogues with many of these distributors regarding potential distribution of the Company's pharmaceutical products in new markets to further expand our presence and growth potential in the international arena."

About China Import and Export Fair

China Import and Export Fair, also know as the Canton Fair, is held twice a year in the spring and autumn since it was inaugurated in 1957. It is China's largest trade fair with the most complete variety of goods with the largest attendance and business turnover. It is co-hosted by the Ministry of Commerce of China and the People's Government of Guangdong Province to help foster the development of China's foreign trade and exchange with the rest of the world in terms of politics, economy and culture. Phase three of the Canton Fair, held from May 1st to 5th, included companies from five industries, including medicines, medical devices and health products, textiles and garments, and food and native products. Thousands of exhibitors representing Chinese international trade companies and manufacturers exhibited over 150,000 types of high quality goods at competitive prices, including specialty products from the various regions in China, bringing a new meaning to the phrase "Made in China". To learn more, please visit http://www.cantonfair.org.cn/en/index.asp .

About China Sky One Medical, Inc.

China Sky One Medical, Inc., a Nevada corporation, is a holding company. The Company engages in the manufacturing, marketing and distribution of pharmaceutical, medicinal and diagnostic products. Through its wholly-owned subsidiaries, Harbin Tian Di Ren Medical Science and Technology Company ("TDR"), Harbin First Bio-Engineering Company Limited ("First"), Heilongjiang Tianlong Pharmaceutical, Inc. ("Tianlong") and Peng Lai Jin Chuang Pharmaceutical Company ("Jin Chuang") the Company manufactures and distributes over-the-counter pharmaceutical products, which make up its major revenue source. For more information, visit http://www.cski.com.cn .

Safe Harbor Statement

Certain of the statements made in the press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by the use of forward- looking terminology such as "believe," "expect," "may," "will," "should," "project," "plan," "seek," "intend," or "anticipate" or the negative thereof or comparable terminology. Such statements typically involve risks and uncertainties. Actual results could differ materially from the expectations reflected in such forward-looking statements as a result of a variety of factors, including the risks associated with the ability to expand the Company's customer base, the execution of signed Letters of Intent, and growth and expansion opportunities in international markets, and other risk factors detailed in reports filed with the Securities and Exchange Commission from time to time.

For more information, please contact:

Company Contact:

China Sky One Medical, Inc.

Mr. Stanley Hao, CFO

Tel: +86-0451-8703-2617

Email: stanleyhao@cski.com.cn

Investor Relations Contact:

CCG Investor Relations

Ms. Lei Huang, Account Manager

Tel: +1-646-833-3417

Email: lei.huang@ccgir.com

Web: http://www.ccgirasia.com

Ms. Mabel Zhang, Vice President

Tel: +1-310-954-1353

Email: mabel.zhang@ccgir.com

Source: China Sky One Medical, Inc.
Related Stocks:
NASDAQ:CSKI
collection